Alexis Jones, APRN
Family · West Valley City, UTNPI 1538736731
Payments from drug & device makers
Across 41 payments — averaging $17.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$116
- Lilly USA, LLC$111
- Axsome Therapeutics, Inc.$76
- Amgen$72
- Organon$64
- AstraZeneca$41
- plus $240 from 11 others
What the payments were for
- Food & beverage$720100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 6 | $116 |
| Lilly USA, LLC | 6 | $111 |
| Axsome Therapeutics, Inc. | 4 | $76 |
| Amgen | 3 | $72 |
| Organon | 4 | $64 |
| AstraZeneca | 3 | $41 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $37 |
| Corcept Therapeutics | 2 | $32 |
| Novo Nordisk | 2 | $31 |
| Idorsia Pharmaceuticals US Inc | 2 | $27 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| Merck | 1 | $21 |
| Pfizer | 1 | $17 |
| Antares Pharma, Inc. | 1 | $15 |
| Lucid Diagnostics Inc. | 1 | $14 |
| Bayer | 1 | $13 |
| Sumitomo Pharma America, Inc. | 1 | $12 |
How this compares
$720 in reported general payments places this provider in the 65th percentile of 1,460 family providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 30 | $554 |
| Cefdinir | 33 | $534 |
| Doxycycline Monohydrate | 25 | $292 |
| Cephalexin | 45 | $245 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 22 | $211 |
| Prednisone | 57 | $113 |
| Lisinopril | 13 | $105 |
| Azithromycin | 27 | $80 |
| Amoxicillin | 17 | $74 |
| Atorvastatin Calcium | 13 | $66 |
| Fluconazole | 11 | $40 |
Paid to pharmacies, not to this prescriber.
Other family in West Valley City
- Julie LuckartWest Valley City$95K
- Riley WorthSandy$1.1M
- Katrina BawdenSalt Lake City$446K
- Cortnee RomanSalt Lake City$374K
- Jared ThorleySalt Lake City$368K
- Stephanie GodfreyLindon$358K
- Mary SteinbackSalt Lake City$189K
- Shannon FordSouth Jordan$186K
- Jennalyn MayeuxSalt Lake City$151K
- Brett RawlinsKaysville$149K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.